Drug Trial Radar · NCT04503629
A Phase 2 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers.
Last checked: Nov 19, 2026Latest source record: Aug 7, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
150
Actual
Start
Oct 9, 2018
Primary completion
May 17, 2019
Study completion May 17, 2019
Sponsor
- Lead sponsor
- Sihuan Pharmaceutical Holdings Group Ltd.Industry
- Sponsor type
- Industry
- First posted
- Aug 7, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A phase 2,double-blinded, double dummy, parallel, positive drug, randomised controlled multicenter trial to evaluate efficacy and safety of 4 weeks treatment of Anaprazole 20mg QD, 40mg QD compared with rabeprazole 10mg QD in patients with duodenal ulcers.
Conditions
- Duodenal Ulcer,DU
Interventions
Anaprazole SodiumDrug
Anaprazole Sodium 20mg
Anaprazole SodiumDrug
Anaprazole Sodium 40mg
Rabeprazole sodiumDrug
Rabeprazole sodium 10mg
Primary outcomes
What the sponsor says the trial is designed to measure.
- The endoscopic healing rate of duodenal ulcers at week 4.Time frame: Treatment of 4 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The Fisrst Affiliated Hospital of NanChang University
Nanchang, Jiangxi, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.